Sulbactam is a medicine that helps other antibiotics work better. It stops certain bacteria from destroying the main antibiotic. This means the antibiotic can fight more types of infections, making treatment more effective.
Every report comes from a Lived member, sent anonymously.
No reports yet
Add what worked for you with the search bar below
Sulbactam is an antibiotic ingredient that is always given as part of a combination. In the US it comes in two prescription products, both given by injection, usually in a hospital. Ampicillin-sulbactam, sold as Unasyn and as generic versions, pairs sulbactam with ampicillin, a penicillin-type antibiotic. It is used for skin infections, infections inside the abdomen and gynecological infections caused by bacteria that have become resistant to ampicillin alone. In children 1 year and older, it is approved for skin infections. Xacduro pairs sulbactam with durlobactam. It is approved for adults 18 and older with pneumonia that developed in the hospital or on a ventilator and is caused by Acinetobacter baumannii, a hard-to-treat bacterium that often resists many antibiotics, including carbapenems, a group of broad-spectrum antibiotics often used for serious hospital infections. US infectious disease guidance now treats Xacduro, given together with a carbapenem, as the preferred treatment for serious infections from carbapenem-resistant Acinetobacter. It is not meant for pneumonia caused by other bacteria.
Many bacteria defend themselves by making enzymes called beta-lactamases, which break down penicillins and related antibiotics before they can work. Sulbactam blocks many of these enzymes. In ampicillin-sulbactam, that protection lets ampicillin keep doing its job, which is to damage the bacterial cell wall so the bacteria die. Sulbactam also has its own killing effect on Acinetobacter, because it attacks proteins the bacterium needs to build its cell wall. Acinetobacter often makes enzymes that destroy sulbactam, though. In Xacduro, durlobactam blocks those enzymes, so enough sulbactam survives to work. Durlobactam has no antibacterial effect of its own.
Ampicillin-sulbactam is given into a vein (IV) over 15 to 30 minutes or as a deep injection into a muscle, typically every 6 hours. The dose is listed as the combined amount of both ingredients, so a 3 g dose contains 2 g of ampicillin and 1 g of sulbactam. Children receive it by IV, with the dose based on weight, and in studies most then finished treatment with an antibiotic taken by mouth. Xacduro is given by IV infusion over 3 hours, every 6 hours in adults with typical kidney function, for 7 to 14 days. Both medicines leave the body through the kidneys, so the care team spaces doses further apart when kidney function is reduced, and gives Xacduro more often when the kidneys clear drugs unusually fast. People on dialysis receive their dose after the session.
With ampicillin-sulbactam, the most common problems are pain or irritation where the injection or IV goes in, diarrhea and rash. With Xacduro, which is used in very ill people, the most common findings in its main trial were abnormal liver tests, diarrhea, anemia (a low red blood cell count) and low potassium, so blood tests are checked during treatment. Any antibiotic can trigger an infection of the colon with Clostridioides difficile (C. diff). Watery or bloody diarrhea, with or without cramps or fever, should be reported to a clinician promptly, even if it starts two months or more after the last dose. Allergic reactions are uncommon but can be severe. During an infusion, tell the nurse right away about trouble breathing, throat tightness or swelling of the face or lips; if this happens outside the hospital, call 911. A rash that spreads, blisters or peels, or yellowing of the skin or eyes (a sign of liver injury, which ampicillin-sulbactam can rarely cause), also needs prompt contact with the care team.
Sulbactam is chemically related to penicillin. People who have had a serious allergic reaction to a penicillin, a cephalosporin or another beta-lactam antibiotic should not receive either product, so mention any past antibiotic allergy, including carbapenems, before treatment starts. Ampicillin-sulbactam should also not be given again to someone who developed jaundice or liver problems from it before. Probenecid, a gout medicine, raises sulbactam levels and is not recommended with Xacduro. Allopurinol, another gout medicine, makes rash from ampicillin noticeably more likely. People with mononucleosis are usually not given ampicillin-type antibiotics because many develop a rash. Ampicillin-sulbactam has been used in pregnancy for decades without an identified pattern of birth defects or miscarriage, but it is still used only when clearly needed. There are no human pregnancy data for durlobactam.
Treatment usually begins in the hospital, often before test results confirm which bacteria are causing the infection. Once cultures come back, the care team may keep the medicine, narrow it or switch to a different antibiotic. It is common to feel better before the course is finished, but skipping doses or stopping early can let the infection return and encourage resistant bacteria. Xacduro is reserved for serious, drug-resistant Acinetobacter infections, usually in people in intensive care. In its main trial, 19% of people given Xacduro had died by day 28, compared with 32% of those given colistin, an older last-resort antibiotic. This shows it is at least as effective as colistin, but these infections remain dangerous and recovery often depends on the person's overall illness. Kidney function, liver tests and blood counts are usually checked during treatment.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Sulbactam, what you've noticed, or ask the community a question.